JPH0124131B2 - - Google Patents

Info

Publication number
JPH0124131B2
JPH0124131B2 JP58502639A JP50263983A JPH0124131B2 JP H0124131 B2 JPH0124131 B2 JP H0124131B2 JP 58502639 A JP58502639 A JP 58502639A JP 50263983 A JP50263983 A JP 50263983A JP H0124131 B2 JPH0124131 B2 JP H0124131B2
Authority
JP
Japan
Prior art keywords
ibuprofen
caffeine
caffein
analgesic
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP58502639A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59501413A (ja
Inventor
Aburahamu Sanshain
Yuujin Emu Rasuka
Kyaroru Ii Shiigeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RICHAADOSON BITSUKUSU Ltd
Original Assignee
RICHAADOSON BITSUKUSU Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RICHAADOSON BITSUKUSU Ltd filed Critical RICHAADOSON BITSUKUSU Ltd
Publication of JPS59501413A publication Critical patent/JPS59501413A/ja
Publication of JPH0124131B2 publication Critical patent/JPH0124131B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP58502639A 1982-07-22 1983-07-21 イブプロフェンを含む改良した鎮痛性及び抗炎症性組成物 Granted JPS59501413A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US400645GBEJP 1982-07-22
US06/400,645 US4420483A (en) 1982-07-22 1982-07-22 Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Publications (2)

Publication Number Publication Date
JPS59501413A JPS59501413A (ja) 1984-08-09
JPH0124131B2 true JPH0124131B2 (en, 2012) 1989-05-10

Family

ID=23584445

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58502639A Granted JPS59501413A (ja) 1982-07-22 1983-07-21 イブプロフェンを含む改良した鎮痛性及び抗炎症性組成物

Country Status (16)

Country Link
US (1) US4420483A (en, 2012)
JP (1) JPS59501413A (en, 2012)
AT (1) AT389051B (en, 2012)
AU (1) AU560092B2 (en, 2012)
BE (1) BE897355A (en, 2012)
CA (1) CA1217428A (en, 2012)
CH (1) CH659946A5 (en, 2012)
DE (1) DE3390114T1 (en, 2012)
FR (1) FR2530468B1 (en, 2012)
GB (1) GB2132891B (en, 2012)
IE (1) IE55366B1 (en, 2012)
IT (1) IT1206693B (en, 2012)
NL (1) NL190923C (en, 2012)
SE (1) SE466889B (en, 2012)
WO (1) WO1984000487A1 (en, 2012)
ZA (1) ZA835325B (en, 2012)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3348444C2 (de) * 1982-07-22 1995-02-02 Richardson Vicks Inc Analgetische und antiinflammatorische Mittel
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
AU5132893A (en) * 1992-09-29 1994-04-26 Mcneil-Ppc, Inc. Ibuprofen-caffeine combinations
AU672279B2 (en) * 1992-12-21 1996-09-26 Procter & Gamble Company, The Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
AU676315B2 (en) * 1993-06-30 1997-03-06 Takeda Chemical Industries Ltd. Stabilized solid pharmaceutical preparation and method of producing the same
JPH09502202A (ja) * 1993-09-07 1997-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー プロピオン酸非ステロイド系抗炎症剤のアミノ酸塩とカフェインを含有した組成物
JPH0987174A (ja) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd 鎮痛性および抗炎症性組成物
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US20020177626A1 (en) * 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
USD472507S1 (en) 2001-06-06 2003-04-01 Campagnolo Srl Spoked wheel for bicycles
JP2003277258A (ja) * 2002-03-20 2003-10-02 Ss Pharmaceut Co Ltd 片頭痛治療剤
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
US20050065172A1 (en) * 2003-09-23 2005-03-24 Shah Indukumar G. Solid dosage form comprising caffeine
WO2009073946A1 (en) * 2007-12-12 2009-06-18 Multi Formulations Ltd. Particles in a capsule
ES2932980T3 (es) * 2014-08-28 2023-01-30 Sanofi Aventis Deutschland Comprimido recubierto con película para el tratamiento del dolor agudo
CA2958454A1 (en) * 2014-08-28 2016-03-03 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition for the treatment of acute tooth or jaw pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS5697224A (en) * 1979-12-28 1981-08-05 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition

Also Published As

Publication number Publication date
DE3390114T1 (de) 1985-01-10
DE3390114C2 (en, 2012) 1990-07-05
IT1206693B (it) 1989-04-27
JPS59501413A (ja) 1984-08-09
US4420483A (en) 1983-12-13
IE55366B1 (en) 1990-08-29
IT8322172A0 (it) 1983-07-21
GB8406703D0 (en) 1984-04-18
CA1217428A (en) 1987-02-03
GB2132891A (en) 1984-07-18
AT389051B (de) 1989-10-10
SE466889B (sv) 1992-04-27
GB2132891B (en) 1986-05-08
NL190923C (nl) 1994-11-01
IE831714L (en) 1984-01-22
AU560092B2 (en) 1987-03-26
FR2530468B1 (fr) 1987-01-16
SE8401537L (sv) 1984-03-20
WO1984000487A1 (en) 1984-02-16
BE897355A (fr) 1983-11-14
AU1828783A (en) 1984-02-23
ZA835325B (en) 1984-09-26
NL8320239A (nl) 1984-06-01
NL190923B (nl) 1994-06-01
SE8401537D0 (sv) 1984-03-20
FR2530468A1 (fr) 1984-01-27
CH659946A5 (de) 1987-03-13
ATA903883A (de) 1989-03-15

Similar Documents

Publication Publication Date Title
JPH0124131B2 (en, 2012)
EP0114886B1 (en) Improved analgesic and anti-inflammatory compositions comprising caffeine
EP0165308B1 (en) Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
IE64953B1 (en) Use of a composition for the manufacture of a medicament for curing the symptoms of overindulgence
US4464376A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4656177A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US20080004284A1 (en) Method for treating fibromyalgia syndrome and related conditions
US4777174A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
NL8320240A (nl) Verbeterde analgetische en antiflogistische, caffeine-bevattende preparaten en werkwijzen voor de toepassing daarvan.
JP5777906B2 (ja) ロキソプロフェン又はその塩含有の医薬組成物
Kornasoff et al. The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis
JP2018135372A (ja) ロキソプロフェン又はその塩含有の医薬組成物＜３＞
US4587249A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4479956A (en) Analgesic compositions comprising propiram and methods of using same
Porto et al. Gastroduodenal tolerability of nimesulide and diclofenac in patients with osteoarthritis
Mena et al. Response of osteoarthritis to ibuprofen or flurbiprofen
JP2017132819A (ja) ロキソプロフェン又はその塩含有の医薬組成物
Sutton et al. How safe is acetaminophen? Some practical cautions with this widely used agent
Solomon, L. & Abrams Bumadizone calcium in the treatment of rheumatoid arthritis
Aylward et al. Treatment of rheumatoid arthritis with tolmetin: a comparison with alclofenac
Rhind et al. A comparative study of floctafenine (Idarac) and ibuprofen in the treatment of osteoarthrosis
Norman et al. Zimelidine: a placebo-controlled trial in depression
Hossain et al. Floctafenine (Idarac) in the management of rheumatoid arthritis
Harris Managing the acute gout attack
Huskisson et al. FLUPROQUAZONE FOR OSTEOATHRITIS